Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Giulio Perugi, Alessandro Pallucchini, Salvatore Rizzato, Pietro De Rossi, Gabriele Sani, Angelo GI Maremmani, Vito Pinzone & Icro Maremmani. (2019) Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opinion on Pharmacotherapy 20:3, pages 343-355.
Read now
Read now
Ozietta D. Taylor. (2015) Poly Substance Use in Methadone Maintenance Therapy (MMT) Patients. Journal of Human Behavior in the Social Environment 25:8, pages 822-829.
Read now
Read now
Einat Peles, Shaul Schreiber & Miriam Adelson. (2014) Trends in Substance Abuse and Infectious Disease Over 20 Years in a Large Methadone Maintenance Treatment (MMT) Clinic in Israel. Substance Abuse 35:3, pages 226-229.
Read now
Read now
Lin Zhao, William L. Holzemer, Jacqueline P. Tulsky, Mallory O. Johnson & Carol Dawson Rose. (2014) Effect of Methadone Dose on Maintenance Treatment and Health Consequences Among Heroin Addicts in South China. Substance Use & Misuse 49:1-2, pages 13-21.
Read now
Read now
Marta Rodríguez-Arias, María Asunción Aguilar, Carmen Manzanedo & José Miñarro. (2010) Preclinical evidence of new opioid modulators for the treatment of addiction. Expert Opinion on Investigational Drugs 19:8, pages 977-994.
Read now
Read now
Mary
Jeanne Kreek, Lisa Borg, Elizabeth Ducat & Brenda Ray. (2010) Pharmacotherapy in the Treatment of Addiction: Methadone. Journal of Addictive Diseases 29:2, pages 200-216.
Read now
Read now
Erin Cummins & Francesco Leri. (2009) Animal studies trigger new insights on the use of methadone maintenance. Expert Opinion on Drug Discovery 4:5, pages 577-586.
Read now
Read now
Einat Peles, Shirley Linzy, Mary
Jeanne Kreek & Miriam Adelson. (2008) One-Year and Cumulative Retention as Predictors of Success in Methadone Maintenance Treatment: A Comparison of Two Clinics in the United States and Israel. Journal of Addictive Diseases 27:4, pages 11-25.
Read now
Read now
Mary Jeanne Kreek. (2007) Opioids, dopamine, stress, and the addictions. Dialogues in Clinical Neuroscience 9:4, pages 363-378.
Read now
Read now
Articles from other publishers (39)
Eleanor Blair Towers, Daniel A. Shapiro, Jean M. Abel, Anousheh Bakhti-Suroosh, Kristyna Kupkova, David T. Auble, Patrick A. Grant & Wendy J. Lynch. (2023) Transcriptional Profile of Exercise-Induced Protection Against Relapse to Cocaine Seeking in a Rat Model. Biological Psychiatry Global Open Science 3:4, pages 734-745.
Crossref
Crossref
Catarina Cordeiro, Rodrigo Saraiva, Inês Simões, Fátima Ismail & Filipa Novais. (2022) The Hero’s Substitution: Cross Sectional Study about Substitution Therapy for Heroin. Revista Portuguesa de Psiquiatria e Saúde Mental 8:2, pages 77-80.
Crossref
Crossref
Tabitha E Moses, Gary L Rhodes, Emytis Tavakoli, Carl W Christensen, Alireza Amirsadri & Mark K Greenwald. (2022) Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program. Substance Abuse: Research and Treatment 16, pages 117822182211383.
Crossref
Crossref
Patrick S. Thomas, Ellen M. Nielsen, Catherine J. Spellicy, Mark J. Harding, An Ye, Michelle Patriquin, Sara C. Hamon, Thomas R. Kosten & David A. Nielsen. (2021) The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. Psychiatric Genetics 31:3, pages 88-94.
Crossref
Crossref
David A. Gorelick. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
173
186
.
Xiaobin Cao, Chunqing Lin, Changhe Wang & Zunyou Wu. 2020. HIV/AIDS in China. HIV/AIDS in China
177
200
.
Hagit Bonny-Noach. (2019) Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?. Israel Journal of Health Policy Research 8:1.
Crossref
Crossref
Einat Peles, Orna Levran, Matthew Randesi, Jurg Ott, Mary Jeanne Kreek & Miriam Adelson. (2019) Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction. Journal of Addiction Medicine 13:6, pages 430-435.
Crossref
Crossref
Angelo Maremmani, Matteo Pacini & Icro Maremmani. (2019) What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients. International Journal of Environmental Research and Public Health 16:3, pages 447.
Crossref
Crossref
Einat Peles, Shaul Schreiber, Anat Sason & Miriam Adelson. (2018) Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center. Drug and Alcohol Dependence 185, pages 112-119.
Crossref
Crossref
Marcus Herdener, Kenneth M Dürsteler, Erich Seifritz & Carlos Nordt. (2017) Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis. The Lancet Psychiatry 4:4, pages 302-309.
Crossref
Crossref
Einat Peles, Anat Sason, Shaul Schreiber & Miriam Adelson. (2017) Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial. The American Journal on Addictions 26:2, pages 167-175.
Crossref
Crossref
Perrine Roux, Caroline Lions, Antoine Vilotitch, Laurent Michel, Marion Mora, Gwenaelle Maradan, Fabienne Marcellin, Bruno Spire, Alain Morel & Patrizia M. Carrieri. (2016) Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Harm Reduction Journal 13:1.
Crossref
Crossref
Yan Zhou, Hilary Briggs & Mary Jeanne Kreek. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
1003
1011
.
Matteo Pacini, Angelo Giovanni Icro Maremmani, Mauro Ceccanti & Icro Maremmani. (2015) Former Heroin-Dependent Alcohol Use Disorder Patients. Prevalence, Addiction History and Clinical Features. Alcohol and Alcoholism 50:4, pages 451-457.
Crossref
Crossref
David A. Gorelick. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
381
404
.
Marcus Baumeister, Marc Vogel, Kenneth M Dürsteler-MacFarland, Urs Gerhard, Johannes Strasser, Marc Walter, Gerhard A Wiesbeck & Sylvie A Petitjean. (2014) Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Substance Abuse Treatment, Prevention, and Policy 9:1.
Crossref
Crossref
Xiaobin Cao, Zunyou Wu, Keming Rou, Li Li, Chunqing Lin, Changhe Wang, Wei Luo, Lin Pang, Wenyuan Yin & Jianhua Li. (2014) Retention and its predictors among methadone maintenance treatment clients in China: A six-year cohort study. Drug and Alcohol Dependence 145, pages 87-93.
Crossref
Crossref
Melissa J. Stewart, Heather G. Fulton & Sean P. Barrett. (2014) Powder and Crack Cocaine Use Among Opioid Users. Journal of Addiction Medicine 8:4, pages 264-270.
Crossref
Crossref
Miriam Adelson, Shaul Schreiber, Anat Sason & Einat Peles. (2014) Are 2 Weeks of “Take-Home” Privileges Beneficial for Patients' Long-term Outcome in a Methadone Maintenance Treatment Program?. Journal of Addiction Medicine 8:3, pages 170-175.
Crossref
Crossref
Jean M. Bidlack. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
387
418
.
Helen Fox & Rajita Sinha. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
217
265
.
Mary Jeanne Kreek, Orna Levran, Brian Reed, Stefan D. Schlussman, Yan Zhou & Eduardo R. Butelman. (2012) Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. Journal of Clinical Investigation 122:10, pages 3387-3393.
Crossref
Crossref
Wim van den Brink. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
235
261
.
Francesco Leri, Yan Zhou, Brendan Carmichael, Erin Cummins & Mary Jeanne Kreek. (2012) Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression. European Neuropsychopharmacology 22:2, pages 143-152.
Crossref
Crossref
Mary Jeanne Kreek. (2011) Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. Annals of the New York Academy of Sciences 1231:1, pages 65-72.
Crossref
Crossref
Lei Li, Rassamee Sangthong, Virasakdi Chongsuvivatwong, Edward McNeil & Jianhua Li. (2011) Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China. Drug and Alcohol Dependence 116:1-3, pages 246-249.
Crossref
Crossref
Yan Zhou, Dmitri Proudnikov, Vadim Yuferov & Mary Jeanne Kreek. (2010) Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. Brain Research 1314, pages 235-252.
Crossref
Crossref
RICHARD SENBANJO, KIM WOLFF, E. JANE MARSHALL & JOHN STRANG. (2009) Persistence of heroin use despite methadone treatment: Poor coping self-efficacy predicts continued heroin use. Drug and Alcohol Review 28:6, pages 608-615.
Crossref
Crossref
Francesco Leri, Yan Zhou, Benjamin Goddard, AnneMarie Levy, Derek Jacklin & Mary Jeanne Kreek. (2009) Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain. European Neuropsychopharmacology 19:4, pages 238-249.
Crossref
Crossref
David H. Epstein, John Schmittner, Annie Umbricht, Jennifer R. Schroeder, Eric T. Moolchan & Kenzie L. Preston. (2009) Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug and Alcohol Dependence 101:1-2, pages 92-100.
Crossref
Crossref
David A Nielsen, Vadim Yuferov, Sara Hamon, Colin Jackson, Ann Ho, Jurg Ott & Mary Jeanne Kreek. (2008) Increased OPRM1 DNA Methylation in Lymphocytes of Methadone-Maintained Former Heroin Addicts. Neuropsychopharmacology 34:4, pages 867-873.
Crossref
Crossref
Mary Jeanne Kreek, Yan Zhou, Eduardo R Butelman & Orna Levran. (2009) Opiate and cocaine addiction: from bench to clinic and back to the bench. Current Opinion in Pharmacology 9:1, pages 74-80.
Crossref
Crossref
M.J. Kreek, S.D. Schlussman, B. Reed, Y. Zhang, D.A. Nielsen, O. Levran, Y. Zhou & E.R. Butelman. (2009) Bidirectional translational research: Progress in understanding addictive diseases. Neuropharmacology 56, pages 32-43.
Crossref
Crossref
M.J. Kreek, L. Borg, Y. Zhou & I. Kravets. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
3177
3207
.
Francesco Leri, Robert E Sorge, Erin Cummins, David Woehrling, James G Pfaus & Jane Stewart. (2007) High-Dose Methadone Maintenance in Rats: Effects on Cocaine Self-Administration and Behavioral Side Effects. Neuropsychopharmacology 32:11, pages 2290-2300.
Crossref
Crossref
&NA;. (2007) Few pharmacotherapies appear effective in the treatment of dual substance abuse and dependence. Drugs & Therapy Perspectives 23:8, pages 13-15.
Crossref
Crossref
Einat Peles, Gershon Bodner, Mary Jeanne Kreek, Vera Rados & Miriam Adelson. (2006) Corrected‐QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients—a cross‐sectional study. Addiction 102:2, pages 289-300.
Crossref
Crossref
George A Kenna, Darci M Nielsen, Patricia Mello, Alison Schiesl & Robert M Swift. (2007) Pharmacotherapy of Dual Substance Abuse and Dependence. CNS Drugs 21:3, pages 213-237.
Crossref
Crossref